ClinicalTrials.Veeva

Menu

One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses

C

Contamac

Status

Completed

Conditions

Ametropia

Treatments

Device: Definitive 65 contact lenses
Device: Definitive 65 HPT contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT02312323
CM-001-002

Details and patient eligibility

About

Comparison of different contact lens materials.

Full description

This is a 1-month, open-label, bilateral, parallel-group, randomised, daily wear study. Two-thirds of the subjects will wear the Test lenses in both eyes, and one-third will wear the Control lenses in both eyes.

Enrollment

35 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • willing and able to sign informed consent form
  • ages 18 years or older
  • Subjects must have owned spectacles or contact lenses prior to enrolment for this trial
  • Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm)
  • Astigmatic power ≤0.75 D

Exclusion criteria

  • Eye injury or surgery within 3 months immediately prior to enrolment for this trial
  • Pre-existing ocular irritation that would preclude contact lens fitting
  • Currently enrolled in an ophthalmic clinical trial
  • Evidence of systemic or ocular abnormality, infection or disease which is likely to affect successful wear of contact lenses or use of the accessory solutions, as determined by the investigator
  • Any use of medications for which contact lens wear could be contradicted, as determined by the investigator
  • Current extended-wear users (sleep-in overnight)
  • Current monovision lens wearers
  • Pregnant women and nursing mothers
  • Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 2 patient groups

Definitive 65 HPT
Experimental group
Description:
The Test product were the Definitive 65 (Filcon V4) lenses with Hydra PEG surface coating. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Treatment:
Device: Definitive 65 HPT contact lenses
Definitive 65
Active Comparator group
Description:
The Control product was the commercially available Definitive 65 (Efrofilcon A) lens. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.
Treatment:
Device: Definitive 65 contact lenses

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems